Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 May 5:5:31.
doi: 10.1186/1748-717X-5-31.

Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients

Imjai Chitapanarux  1 , Taned Chitapanarux, Patrinee Traisathit, Sudkaneung Kudumpee, Ekkasit Tharavichitkul, Vicharn Lorvidhaya
Affiliations
Randomized Controlled Trial

Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients

Imjai Chitapanarux et al. Radiat Oncol. .

Abstract

Background: Radiation-induced diarrhea is frequently observed during pelvic radiotherapy. This study was performed to determine the ability of a probiotic containing live lactobacillus acidophilus plus bifidobacterium bifidum to reduce the incidence of radiation-induced diarrhea in locally advanced cervical cancer patients.

Methods: Patients who were undergoing pelvic radiotherapy concurrent with weekly cisplatin were randomly assigned to a study drug or placebo, in a double-blind study. Diarrhea was graded weekly according the Common Toxicity Criteria (CTC) system. Stool consistency and white and red blood cell count in stool were also assessed. The primary endpoint was to reduce the incidence of diarrhea, defined by a CTC grade 2 or more, and the need for anti-diarrheal medication.

Results: A total of 63 patients were enrolled. Grade 2 -3 diarrhea was observed in 45% of the placebo group (n = 31) and 9% of the study drug group (n = 32) (p = 0.002). Anti-diarrheal medication use was significantly reduced in the placebo group (p = 0.03). The patients in the study drug group had a significantly improved stool consistency (p < 0.001).

Conclusions: Live lactobacillus acidophilus plus bifidobacterium bifidum reduced the incidence of radiation-induced diarrhea and the need for anti-diarrheal medication and had a significant benefits on stool consistency.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Trial profile.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Resbeut M, Marteau P, Cowen D, Richaud P, Bourdin S, Dubois JB, Mere P, N'Guyen TD. A randomized double blind placebo controlled multicenter study of medalazine for the prevention of acute radiation enteritis. Radiother Oncol. 1997;44:59–63. doi: 10.1016/S0167-8140(97)00064-9. - DOI - PubMed
    1. Ajlouni M. Radiation-induced proctitis. Curr Treat Opt Gastroenterol. 1999;2:20–6. doi: 10.1007/s11938-999-0014-5. - DOI - PubMed
    1. McGough C, Baldwin C, Frost G, Andreyev HIN. Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy. British Journal of Cancer. 2004;90:2278–87. - PMC - PubMed
    1. Gami B, Harrington K, Blake P, Dearnaley D, Tait D, Davies J, Norman AR, Andreyev HJN. How patients manage gastrointestinal symptoms after pelvic malignancy. Aliment Pharmacol Ther. 2003;18:987–94. doi: 10.1046/j.1365-2036.2003.01760.x. - DOI - PubMed
    1. Andreyev HJN, Amin Z, Blake P, Dearnaley D, Tait D, Vlavianos P. GI symptoms developing after pelvic radiotherapy require gastroenterological review. Gut. 2003;52(suppl 1):A90.

Publication types

MeSH terms